Information on FANCD2

Basic details

Name: Fanconi anemia, complementation group D2 | Acronym: FANCD2
Alt. names:

Gene: FANCD2 | MOI: Autosomal recessive | Mechanism of action:

No. of cases in DB: 0 | First reported in: 2001

Last updated on: 2023-02-28 16:41:18 by

OMIM: 227646

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Specific treatments can help manifestations (eg, oral androgens for blood counts; G-CSF for neutrophil count); HSCT can be curative, but solid tumor risk may remain; Surveillance for complications such as bone marrow failure is recommended. Individuals with FA may manifest a variety of congenital malformations, and awareness may allow prompt detection and management. Refs. PMIDs: 17436244; 20301575; 22720145; 23285130

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

0 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Bone marrow hypocellularityarrow icon 25 (89.3%) 0 (0.0%) 3 (10.7%)
2 Microcephalyarrow icon 25 (89.3%) 0 (0.0%) 3 (10.7%)
3 Small for gestational agearrow icon 24 (82.8%) 0 (0.0%) 5 (17.2%)
4 Abnormality of skin pigmentationarrow icon 19 (65.5%) 0 (0.0%) 10 (34.5%)
5 Microphthalmiaarrow icon 17 (60.7%) 0 (0.0%) 11 (39.3%)
6 Intellectual disabilityarrow icon 9 (31.0%) 0 (0.0%) 20 (69.0%)
7 Short thumbarrow icon 9 (31.0%) 0 (0.0%) 20 (69.0%)
8 Hydrocephalusarrow icon 4 (13.8%) 0 (0.0%) 25 (86.2%)
9 Hypoplasia of the corpus callosumarrow icon 4 (13.8%) 0 (0.0%) 25 (86.2%)
10 Patent ductus arteriosusarrow icon 4 (13.8%) 0 (0.0%) 25 (86.2%)
11 Pelvic kidneyarrow icon 4 (13.8%) 0 (0.0%) 25 (86.2%)
12 Absent radiusarrow icon 3 (10.3%) 0 (0.0%) 26 (89.7%)
13 Absent thumbarrow icon 3 (10.3%) 0 (0.0%) 26 (89.7%)
14 Attention deficit hyperactivity disorderarrow icon 3 (10.3%) 0 (0.0%) 26 (89.7%)
15 Low-set earsarrow icon 3 (10.3%) 0 (0.0%) 26 (89.7%)
16 Preaxial hand polydactylyarrow icon 3 (10.3%) 0 (0.0%) 26 (89.7%)
17 Agenesis of corpus callosumarrow icon 2 (6.9%) 0 (0.0%) 27 (93.1%)
18 Aplasia of the 1st metacarpalarrow icon 2 (6.9%) 0 (0.0%) 27 (93.1%)
19 Cafe-au-lait spotarrow icon 2 (6.9%) 0 (0.0%) 27 (93.1%)
20 Hypotelorismarrow icon 2 (6.9%) 0 (0.0%) 27 (93.1%)
21 Micropenisarrow icon 2 (11.8%) 0 (0.0%) 15 (88.2%)
22 Annular pancreasarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
23 Blepharophimosisarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
24 Ectopic kidneyarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
25 Esophageal atresiaarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
26 Hearing impairmentarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
27 Horseshoe kidneyarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
28 Hypergonadotropic hypogonadismarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
29 Hypertelorismarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
30 Partial duplication of thumb phalanxarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
31 Renal duplicationarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
32 Strabismusarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)
33 Tracheoesophageal fistulaarrow icon 1 (3.5%) 0 (0.0%) 28 (96.6%)

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.